Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Quantitative evaluation of SPRR3 expression in esophageal squamous cell carcinoma by qPCR and its potential use as a biomarker.

de A Simão T, Souza-Santos PT, de Oliveira DS, Bernardo V, Lima SC, Rapozo DC, Kruel CD, Faria PA, Ribeiro Pinto LF, Albano RM.

Exp Mol Pathol. 2011 Oct;91(2):584-9. doi: 10.1016/j.yexmp.2011.06.006. Epub 2011 Jul 12.

PMID:
21777580
2.

Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Ren HZ, Pan GQ, Wang JS, Wen JF, Wang KS, Luo GQ, Shan XZ.

Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.

PMID:
20108042
3.

Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.

Ann Surg Oncol. 2009 Sep;16(9):2494-501. doi: 10.1245/s10434-009-0559-5. Epub 2009 Jun 13.

PMID:
19526206
4.

MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.

Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM, Xu LY.

J Surg Oncol. 2012 Feb;105(2):175-82. doi: 10.1002/jso.22066. Epub 2011 Aug 22.

PMID:
21882196
5.

Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.

Zhu S, Li Y, Mi L, Zhang Y, Zhang L, Gong L, Han X, Yao L, Lan M, Chen Z, Zhang W.

Dig Dis Sci. 2011 Dec;56(12):3569-76. doi: 10.1007/s10620-011-1812-x. Epub 2011 Jul 26.

PMID:
21789540
6.

Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.

Faried A, Faried LS, Usman N, Kato H, Kuwano H.

Ann Surg Oncol. 2007 Dec;14(12):3593-601. Epub 2007 Sep 25.

PMID:
17896152
7.

Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.

Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H.

Oncol Rep. 2010 Jun;23(6):1625-33.

PMID:
20428818
8.

Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Mori Y, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Kurehara H, Mori R, Tomoda K, Ogawa R, Katada T, Harata K, Fujii Y.

Oncol Rep. 2007 Oct;18(4):981-5.

PMID:
17786363
9.

[Expression of ERK1/2 MAPK signaling transduction pathway in esophageal cancers in Kazakh patients].

Zheng ST, Liu T, Middottuersun A, Huo Q, Liu Q, Huang CG, Feng JG, Lü GD, Wang X, Lin RY, Sheyhidin I, Lu XM.

Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):421-5. Chinese.

PMID:
21875481
10.

Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.

Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda S, Higashiyama M, Watanabe G, Imamura M, Shimada Y.

Clin Cancer Res. 2005 Apr 1;11(7):2597-605.

11.

The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.

Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, Sugito N, Tomoda K, Mori R, Harada K, Katada T, Ogawa R, Fujii Y, Kuwabara Y.

Oncol Rep. 2007 Sep;18(3):601-9.

PMID:
17671707
13.

Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.

Shirakawa M, Fujiwara Y, Sugita Y, Moon JH, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Mori M, Doki Y.

Oncol Rep. 2012 Apr;27(4):940-6. doi: 10.3892/or.2011.1607. Epub 2011 Dec 22.

14.

Expression patterns of aurora kinase B, heat shock protein 47, and periostin in esophageal squamous cell carcinoma.

Kwon YJ, Lee SJ, Koh JS, Kim SH, Kim YJ, Park JH.

Oncol Res. 2009;18(4):141-51.

PMID:
20112500
15.

Altered expression of ezrin in esophageal squamous cell carcinoma.

Zeng H, Xu L, Xiao D, Zhang H, Wu X, Zheng R, Li Q, Niu Y, Shen Z, Li E.

J Histochem Cytochem. 2006 Aug;54(8):889-96. Epub 2006 Apr 3.

PMID:
16585385
16.

Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues.

Zhang G, Zhang Q, Zhang Q, Yin L, Li S, Cheng K, Zhang Y, Xu H, Wu W.

J Cancer Res Clin Oncol. 2010 Apr;136(4):587-94. doi: 10.1007/s00432-009-0693-2. Epub 2009 Oct 13.

PMID:
19823871
17.

Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.

Xue LY, Hu N, Song YM, Zou SM, Shou JZ, Qian LX, Ren LQ, Lin DM, Tong T, He ZG, Zhan QM, Taylor PR, Lu N.

BMC Cancer. 2006 Dec 22;6:296.

18.

Analysis of HAX-1 gene expression in esophageal squamous cell carcinoma.

Li M, Tang Y, Zang W, Xuan X, Wang N, Ma Y, Wang Y, Dong Z, Zhao G.

Diagn Pathol. 2013 Mar 25;8:47. doi: 10.1186/1746-1596-8-47.

19.

Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.

Sugiura H, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Mori Y, Ogawa R, Katada T, Harata K, Fujii Y.

Oncol Rep. 2008 Mar;19(3):713-9.

PMID:
18288406
20.

Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers.

Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, Prasad TS, Mahmood R, Rao S, Ranganathan P, Sanjeeviah RC, Vijayakumar M, Kumar KV, Montgomery EA, Kumar RV, Pandey A.

Cancer Biol Ther. 2009 Jan;8(1):36-46. Epub 2009 Jan 1.

PMID:
18981721

Supplemental Content

Support Center